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Abstract
Background: Transient arrhythmias can affect transient ischemic dilation (TID) ratios. This study
was initiated to evaluate the frequency and effect of normal heart rate change on TID measures in
routine clinical practice.
Methods: Consecutive patients undergoing stress/rest sestamibi gated myocardial perfusion
scintigraphy were studied (N = 407). Heart rate at the time of stress and rest imaging were
recorded. TID ratios were analyzed in relation to absolute change in heart rate (stress minus rest)
for subjects with normal perfusion and systolic function (Group 1, N = 169) and those with
abnormalities in perfusion and/or function (Group 2, N = 238).
Results: In Group 1, mean TID ratio was inversely correlated with the change in heart rate (r = -
0.47, P < 0.0001). For every increase of 10 BPM in heart rate change, the TID ratio decreased by
approximately 0.06 (95% confidence interval 0.04–0.07). In Group 2, multiple linear regression
demonstrated that the change in heart rate (beta = -0.25, P < 0.0001) and the summed difference
score (beta = 0.36, P < 0.0001) were independent predictors of the TID ratio.
Conclusion: Normal variation in heart rate between the stress and rest components of
myocardial perfusion scans is common and can influence TID ratios in patients with normal and
abnormal cardiac scans.
Background
The assessment of myocardial perfusion with radioactive
flow tracers provides valuable clinical information for
diagnosis and risk stratification [1-3]. Individuals with
normal myocardial perfusion during an adequate stress
procedure are generally regarded as being at low risk for
major cardiac events [4,5]. In addition to perfusion, a
number of ancillary functional parameters can be
extracted from these images [6]. These have been shown
to provide additional prognostic information that is addi-
tive to the clinical and perfusion data alone. For example,
left ventricular systolic function can be assessed with
gated single photon emission computed tomography
(SPECT), left ventricular cavity size can be measured, and
lung uptake measurements can be computed [7-11]. Each
of these parameters has been shown to provide incremen-
tal prognostic information.
"Transient ischemic dilation" (TID) of the left ventricular
cavity is a marker of severe coronary artery disease and
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also been correlated with cardiac events in individuals
with normal perfusion patterns [14]. Since average left
ventricular cavity volume is influenced by heart rate
(faster heart rate leading to smaller volumes due to
reduced filling time) it is possible that TID measurements
may be affected by normal change in heart rate between
the stress and rest images. Falsely elevated and reduced
TID ratios have been reported in individuals experiencing
transient arrhythmias [15]. This study was initiated to
evaluate the frequency and effect of normal heart rate
change on TID measures in routine clinical practice.
Methods
Patient population
Consecutive patients referred to the Nuclear Medicine
Department at St. Boniface General Hospital for gated
SPECT stress/rest sestamibi myocardial perfusion scintig-
raphy between February 2005 and July 2005 were studied.
We excluded individuals who did not complete both
stress and rest imaging (n = 1), who had persistent or
intermittent arrhythmia (n = 6), or where there was miss-
ing heart rate information at the time of the scan acquisi-
tion (n = 41). Patient consent was not required since all
procedures were performed as part of routine clinical
imaging. This manuscript was reviewed and approved in
accordance with the facility's Office of Clinical Research.
Image acquisition and processing
The procedures used in our Nuclear Medicine laboratory
have been previously reported [16]. A two-day protocol
(gated rest with non-gated stress) utilizing treadmill exer-
cise is the preferred procedure in our laboratory. When-
ever possible, beta blockers and calcium-channel
antagonists are withheld for 24–48 hours prior to the
stress procedure, and nitrates are avoided for at least six
hours. Symptom-limited treadmill exercise is performed
with 99mTc-sestamibi injection (500–600 MBq) at peak
exercise followed by 1–3 minutes of exercise post-injec-
tion. For individuals unable to achieve a satisfactory exer-
cise workload, dipyridamole pharmacologic stress is used
(0.56 mg/kg administered intravenously over 4 minutes,
with tracer injection 4 1/2 minutes later). Low-level sup-
plementary exercise is performed whenever possible fol-
lowing dipyridamole infusion for those patients without
a left bundle branch block. Supine, gated SPECT imaging
is commenced 30–60 minutes post-stress and 45–75 min-
utes following the resting tracer injections (ADAC Forte,
Phillips, Milpitas, CA). A one-day procedure (non-gated
rest followed by gated stress) is used in a small number of
cases. In these patients the rest imaging with 99mTc-sesta-
mibi (250–300 MBq) was performed in the morning fol-
lowed by stress imaging (1000 MBq) 2–3 hours later.
Heart rate was recorded immediately prior to stress and
rest image acquisition. When the patient was attached to
an EKG monitor for purposes of gating, the heart rate dis-
played by the monitor was recorded. For the non-gated
scan (usually stress), the technologist counted the radial
pulse for 15 seconds and then multiplied this by 4 to
determine heart rate. Change in heart rate was calculated
as heart rate at the time of stress imaging minus heart rate
at the time of rest imaging. This was subsequently
grouped into tertiles.
Image data was processed using commercially available
software (AutoSPECT and QPS/QGS AutoQUANT, Cedar
Sinai Medical Centre and ADAC Laboratories, Milpitas,
CA) [17-19]. Left ventricular contours were checked visu-
ally and manually adjusted if the computer-generated
automatic contours were found to be incorrect. Briefly,
this software provides a quantitative defect extent and
severity measurement, the summed stress score (SSS),
defined from gender-specific normal limits by adding the
scores from twenty left ventricular segments (0 = normal
to 4 = absent uptake) on the stress sestamibi images.
[20,21]. The summed rest scores (SRS) and summed dif-
ference scores (SDS) provide indices of infarction and
ischemia, respectively. We have previously shown that
there is close agreement between the visual and auto-
mated quantitative assessment in terms of diagnosis and
prognosis [22,23].
An automatic calculation of left ventricular volumes post-
stress and at rest was obtained using a validated algorithm
that operates in three-dimensional space on the recon-
structed short-axis image sets [24]. The TID ratio is derived
from the endocardial volumes as the ratio of the average
left ventricular volume at stress divided by the average vol-
ume at rest. Left ventricular ejection fraction (LVEF) was
derived from 8-frame gated SPECT using the same vali-
dated commercial software package [25].
Image interpretation
Interpretation of the scan data was performed by nuclear
medicine specialists with extensive experience in cardiac
nuclear medicine. Scans were jointly reported by two phy-
sicians, and if necessary a third physician was involved to
reach a consensus. Images were categorized as normal,
equivocal, abnormal with fixed defects, abnormal with fully
reversible defects, or abnormal with partially reversible defects.
For analytic purposes, these categories were recoded using
two variables as follows: normal scan (normal or equivo-
cal) versus abnormal scan (abnormal with fixed or revers-
ible defects); no reversibility (normal, equivocal or
abnormal with fixed defects) versus reversibility (abnor-
mal with fully reversible or partially reversible defects).Page 2 of 9
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with normal perfusion and function (Group 1) and the
other with abnormal perfusion and/or function (Group
2). For classification purposes, normal was defined as a
visual perfusion interpretation of normal or equivocal,
SSS ≤ 3 and LVEF ≥ 45% [26]. All criteria had to be satis-
fied. This group was used to assess the effect of heart rate
change on TID ratio in individuals without detectable
ischemia or impaired systolic function. Group 2 was used
to assess the effect of heart rate change on TID ratio cate-
gorization in patients with abnormal perfusion and/or
systolic function. Nominal upper limits of normal TID
ratios (mean + 1.96 standard deviations) were derived
from Group 1 overall and by tertile in absolute change in
heart rate. TID ratios in Group 2 were categorized accord-
ing to these cutoffs to determine the effect of using a heart
rate stratified normal range.
Statistical analysis
The absolute change in heart rate (stress heart rate minus
rest heart rate) was studied in relation to the automated
TID ratio. The correlation between heart rate change and
TID ratio was assessed in the two study groups separately
using Pearson correlation coefficients. Multivariable lin-
ear regression was used to assess the independence of the
relationship between TID ratio, heart rate change and
ischemic burden as measured by the SDS. Heart rate
change and TID ratio were normally distributed, and
graphical analysis of the residuals was consistent with a
linear relationship. Continuous variables are reported as
mean ± SD, and P < 0.05 is considered to represent a sta-
tistically significant difference. Group comparisons were
performed using ANOVA (continuous variables) or a Chi-
square test (categorical variables). Post hoc pairwise com-
parisons were performed with Fisher's least significant dif-
ference procedure. Statistical analysis was performed with
a commercial software package (Statistica Version 6.1,
StatSoft Inc, Tulsa, OK).
Results
Overall population
The study cohort consisted of 407 patients, of whom 169
(42%) had normal perfusion and systolic function
(Group 1) with the remaining 238 (58%) having abnor-
mal perfusion and/or systolic function (Group 2). Patient
characteristics are summarized (Table 1). As expected,
there were significant differences between these groups.
Differences in variables related to perfusion and systolic
function were in keeping with the group definitions.
Group 1 patients tended to be younger (P = 0.06), more
likely to be female (P < 0.0001), and less likely to require
pharmacologic stress (P < 0.0001). The majority (86%) of
the scans were performed as two-day procedures with gat-
ing of the rest scan. The overall mean change in heart rate
(stress – rest) was 6 ± 9 BPM. Heart rate change was
slightly greater in Group 1 than Group 2 (8 ± 10 vs. 5 ± 9,
P = 0.005). A lower mean TID ratio was seen in Group 1
than Group 2 (1.01 ± 0.12 vs. 1.06 ± 0.12; P = 0.0001).
In the combined study population (Groups 1 and 2) we
looked for factors associated with the difference in heart
rate between stress and rest. Larger changes were inversely
Table 1: Patient demographics and characteristics. Group 1 had normal perfusion and function. Group 2 had abnormal perfusion and/
or function.
All Patients N = 407 Group 1 N = 169 Group 2 N = 238 P value *
Age (years) 65 ± 12 63 ± 13 66 ± 11 0.06
Male (percent) 213 (52%) 69 (41%) 144 (60%) <0.0001
Height (cm) 168 ± 10 166 ± 9 170 ± 10 0.005
Weight (kg) 83.6 ± 16.9 81.4 ± 16.7 85.2 ± 17.0 0.03
Scan protocol (percent)
Two-Day 351 (84%) 148 (88%) 202 (85%) >0.2
Same-Day 56 (14%) 21 (12%) 35 (15%)
Stress method (percent)
Exercise only 173 (43%) 100 (59%) 73 (31%) <0.0001
Dipyridamole 234 (57%) 69 (41%) 165 (69%)
Heart rate (BPM)
Stress scan 70 ± 12 71 ± 13 70 ± 13 0.15
Rest scan 64 ± 12 64 ± 11 64 ± 13 >.2
Change 6 ± 9 8 ± 10 5 ± 9 0.005
Perfusion
SSS 7 ± 8 1 ± 1 11 ± 8 <0.0001
SRS 3 ± 6 0 ± 0 5 ± 7 <0.0001
SDS 4 ± 4 1 ± 1 6 ± 5 <0.0001
LVEF (%) 57 ± 14 64 ± 9 52 ± 15 <0.0001
TID Ratio 1.04 ± 0.12 1.01 ± 0.12 1.06 ± 0.12 0.0001
* Group 1 vs. Group 2Page 3 of 9
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ventricular cavity volume on the stress image (r = -0.11, P
= 0.026). Individuals undergoing pharmacologic stress
showed a smaller difference in heart rate than those
undergoing exercise (mean change 4 ± 8 BPM versus 10 ±
10 BPM, P < 0.0001). Scan protocol also affected change
in heart rate, with a smaller change in those undergoing
same-day scanning (mean change 2 ± 8 BPM) than when
a two-day protocol was used (9 ± 9 BPM; P = 0.0004). Vis-
ually abnormal perfusion, visual reversibility, SSS, SDS,
and LVEF were unrelated to change in heart rate.
Since determinants of TID ratio were anticipated to be
quite different for subjects with normal cardiac perfusion
and function (Group 1) and those with cardiac abnormal-
ities (Group 2), these two groups were analyzed sepa-
rately.
Normal cardiac perfusion and function (Group 1)
There was a significant negative correlation between heart
rate change and the TID ratio in Group 1 (r = -0.47, p <
0.0001). For every increase of 10 BPM in heart rate
change, the TID ratio decreased by approximately 0.06
(95% confidence interval 0.04–0.07) (Figure 1). This
association was demonstrated for both exercise and phar-
macologic stress (r = -0.56, P = 0.0007 and r = -0.41, P =
0.001 respectively), with mean TID ratios that were signif-
icantly different (0.98 ± 0.11 and 1.05 ± 0.12 respectively,
P = 0.0003). Significant correlations between heart rate
change and the TID ratio were also seen for patients
undergoing one-day (r = -0.53, P = 0.013) or two-day (r =
-0.45, P < 0.0001) protocols.
When heart rate change was grouped into tertiles (stress
minus rest lowest tertile less than -2 BPM, highest tertile
greater than 8 BPM), a strong effect on mean TID ratio was
Transient ischemic dilation (TID) ratio in relation to change in heart between stress and rest imaging for Group 1 (normal car-diac p rfusion and functi ) and Group 2 (abn rmal ardiac perfusion and/or function)Figur  1
Transient ischemic dilation (TID) ratio in relation to change in heart between stress and rest imaging for Group 1 (normal car-
diac perfusion and function) and Group 2 (abnormal cardiac perfusion and/or function).
Change in heart rate (stress - rest)
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sons (Figure 2) showed that individuals in the highest ter-
tile of change in heart rate differed significantly from the
other two groups (P < 0.0001).
Abnormal cardiac perfusion and/or function (Group 2)
Of the 238 cases, an inverse correlation was again noted
between change in heart rate and TID ratio (r = -0.25, P <
0.0001). Mean TID ratios were significantly different
between patients undergoing exercise (1.03 ± 0.13) or
pharmacologic stress (1.07 ± 0.11 respectively, P = 0.023),
and between patients undergoing one-day (1.11 ± 0.09)
or two-day protocols (1.05 ± 0.12 respectively, P =
0.0021). Other factors that correlated with TID ratio were
SSS (r = 0.25, P < 0.0001) and SDS (r = 0.36, P < 0.0001).
Multiple linear regression confirmed the independent
effects of change in heart rate (beta = -0.25, P < 0.0001)
and SDS (beta = 0.36, P < 0.0001). Significant differences
in the mean TID ratio were seen when heart rate change
was grouped into tertiles as previously defined (ANOVA P
< 0.0001). Individuals in the highest tertile of change in
heart rate differed significantly from the other two groups
(P < 0.05).
Heart rate stratified categorization
The upper limit of normal TID ratio derived by pooling all
patients in Group 1 was 1.24. Upper limits of normal for
each of the previously defined tertiles of change in heart
rate were 1.27 for the lowest tertile, 1.23 for the middle
tertile, and 1.16 for the highest tertile. The TID ratio for
Group 2 exceeded either the pooled or the rate stratified
cutoff in 21 cases. Of these, 8 (38%) showed discordance
between the two approaches (6 elevated with the rate
stratified range but normal using the pooled cutoff, and 2
normal with the rate stratified range but elevated with a
pooled cutoff).
It is also possible to derive a TID correction for heart rate
change based upon the linear regression for Group 1 (TID
= 1.054 - .0058 * [heart rate change]) which effectively
corrects the TID ratio to a heart rate change of 0. The upper
limit of normal TID ratio decreased from 1.24 (uncor-
rected) to 1.21 (corrected), the more narrowly defined
normal range in keeping with removal of a source of vari-
ability. Seven Group 2 cases showed elevated TID ratios
with the rate adjusted reference range but normal ratios
using the uncorrected range.
Two examples are presented that illustrate opposite effects
of change in heart rate (Figure 3). In one case, heart rate
change (slower with stress) was felt to produce an artifac-
tually elevated TID ratio. The clinical information and
perfusion pattern in this case did not support severe
ischemia. In the other case, heart rate change (faster with
stress) probably produced an artifactually low TID ratio.
The TID ratio was still within the normal pooled range but
the heart rate stratified normal range categorized the TID
ratio as elevated, consistent with the perfusion pattern of
multivessel ischemia. The patient sustained an acute myo-
cardial infarction 11 months after the scan and was found
to have severe triple-vessel coronary artery disease at the
time of coronary angiography. In two additional cases
where the TID ratio was normal according to the conven-
tional pooled upper limit but exceeded a rate-stratified
upper limit, coronary angiography performed subsequent
to the scan confirmed severe triple-vessel coronary artery
disease. One (TID ratio 1.20, change in heart rate 15 BPM)
underwent successful percutaneous intervention for a
severe proximal LAD stenosis and the other (TID ratio
1.20, change in heart rate 16 BPM) required surgical revas-
cularization.
Discussion
This study shows that differences in heart rate between the
stress and rest sestamibi myocardial perfusion scans are
associated with indices of left ventricular volume such as
the TID ratio. A direct physiologic link cannot be defined
from this study, and further work would be required to
establish the mechanism. If venous return remains con-
stant, then changes in heart rate must be accompanied by
a reciprocal change in stroke volume. It is not surprising
that heart rate effects on left ventricular volume measure-
ments can be identified under conditions of overt arrhyth-
mia. Several cases of falsely elevated and falsely reduced
TID ratio have previously been reported [15]. What is sur-
prising in the current study is that this effect is clearly evi-
dent even within the range of normal variation in heart
rate, though it still only accounted for a minority of the
variation in TID ratio. This association does not prove that
the variation in heart rate is producing an actual change in
ventricular volumes, however. Diastole is disproportion-
ately prolonged at slower heart rates, and end diastolic
data would be expected to make a greater contribution to
the summed left ventricular data (the basis for the QPS
estimation of TID whether acquisitions are gated or non-
gated). This could in turn artifactually elevate the summed
left ventricular volume at slower heart rates and poten-
tially contribute to the effect of heart rate on the TID ratio.
If this were the sole explanation then one might expect
that gated SPECT acquisition from our normals (Group 1)
would show a negative correlation between heart and
summed left ventricular volume but not with end-diasto-
lic volume (EDV) or end-systolic volume (ESV). In fact,
the negative correlation existed between all three meas-
ures and heart rate was only marginally stronger with the
summed volume (summed volume r = -0.27, p = 0.001;
EDV r = -0.22, p = 0.007; ESV r = -0.18, p = 0.03). There-
fore, the mechanism(s) may be more complicated and
needs to be further clarified.Page 5 of 9
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Effect of heart rate change on mean transient ischemic dilation (TID) ratioFigure 2
Effect of heart rate change on mean transient ischemic dilation (TID) ratio. (a) Group1 consists of patients with 
normal cardiac perfusion and function. (b) Group 2 consists of patients with abnormal cardiac perfusion and/or function.
a)
b)
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Illustrative cases demonstrating how change in heart rate can affect transient ischemic dilation (TID) ratiosFigu e 3
Illustrative cases demonstrating how change in heart rate can affect transient ischemic dilation (TID) ratios. (a) 
Low-risk left ventricular perfusion pattern (equivocal in the posterobasal segment due to possible attenuation artifact) with an 
elevated TID ratio. Heart rate was slower with stress than with rest imaging (78 BPM and 98 BPM, respectively, with absolute 
difference -20 BPM). (b) Severely abnormal left ventricular perfusion with a borderline TID ratio. Multiple reversible defects 
(arrowheads) indicate multivessel ischemia. Heart rate was faster with stress than with rest imaging (75 BPM and 60 BPM, 
respectively, absolute difference 15 BPM) and the TID ratio was abnormal using a rate stratified normal range.
a)
b)
BMC Nuclear Medicine 2007, 7:1 http://www.biomedcentral.com/1471-2385/7/1It is not surprising that this effect has not been reported
from centres that use a thallium-sestamibi dual-isotope
protocol or thallium stress-redistribution imaging [27,
28]. Rest and stress imaging are both completed within a
very short period of time and there is probably little
opportunity for observing significant temporal or normal
changes in heart rate. This is consistent with published
reports that the normal range for single-tracer stress/rest
sestamibi examinations completed on two days (less than
1.25) is slightly greater than the normal range for a one-
day single-tracer rest/stress sestamibi examination (less
than 1.18) [29, 30]. These small differences appear to be
important in categorizing the TID ratio. We found disa-
greement in the characterization of the TID ratio as ele-
vated in 8 of 21 cases, indicating possible confounding by
heart rate variation. This could have important clinical
implications, since one group has reported that an ele-
vated TID ratio is an independent and incremental prog-
nostic marker of cardiac events even in patients with
otherwise normal myocardial perfusion scans [31].
A limitation of this study is the lack of clinical outcome
data. Whether a heart rate adjusted TID ratio would be
superior to the unadjusted TID ratio for the prediction of
ischemia-related events is unclear. In theory, a TID ratio
whose interpretation is not modified by simple differ-
ences in heart rate should provide a more accurate and
powerful predictive measure but this still needs to be ver-
ified. However, in some patients, heart rate change
between stress and rest studies may affect measured left
ventricular volumes, and therefore give an erroneous TID
ratio, leading to a false positive diagnosis of ischemia, or
conversely, a falsely normal value. Our study did not
include a true normal population of low-risk individuals.
Some of the individuals with normal left ventricular per-
fusion and function (Group 1) probably had mild coro-
nary artery disease, and this could bias our results. Our use
of the peripheral pulse for assessing heart rate on the non-
gated scan is obviously prone to error. Electrocardio-
graphic measurement of heart rate for both the stress and
rest scans would have been preferable, but this is not rou-
tine practice in many nuclear medicine departments. The
timing between tracer injection and scanning was not
carefully standardized, and could affect the heart rate
assessment especially for the stress portion. Therefore, we
may have underestimated the effect of heart rate variabil-
ity on the TID ratio due to inaccuracy in heart rate meas-
urement. For examinations completed on two days there
was a greater average change in heart rate (stress heart rate
faster than rest heart rate) than when a one day protocol
was used. In part, this may reflect the effects of temporar-
ily withdrawing rate-limiting anti-ischemic medication
for the stress test. Unfortunately, we do not have informa-
tion about patient medication use immediately prior to
the stress and rest scans.
Conclusion
In summary, normal variation in heart rate between the
stress and rest components of myocardial perfusion scans
is common and can influence TID ratios in normal and
abnormal cardiac scans. Further work is required to deter-
mine if rate specific reference ranges for TID ratio will
improve the predictive value of this important index.
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